Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1 -infected individuals correlate with immunosuppression and disease

Abstract

Measurement of HIV neutralization and enhancement in complement-containing serum samples using a complement receptor carrying target may provide data of clinical relevance. Neutralization appears to be associated with a favourable prognosis whereas high titre enhancing antibodies predict rapid progression of HIV disease.